Bortezomib will enhance the degree or influence of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. Amplified flibanserin adverse results may well take place if coadministered with multiple weak CYP3A4 inhibitors. Significant: The drug information on this web page is meant to generally be academic. It is not a https://nv-513898765.timeblog.net/62501346/thalicarpine-an-overview